Aflibercept ameliorates retinal pericyte loss and restores perfusion in streptozotocin-induced diabetic mice

INTRODUCTION: Anti-vascular endothelial growth factor (VEGF) agents are used worldwide for advanced-stage diabetic retinopathy (DR). In contrast, apart from blood glucose control, there are no specific treatments that can limit the progression of early-stage DR that starts with pericyte loss and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Eoi Jong, Choi, Jeong A, Koh, Jae-Young, Yoon, Young Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Pathophysiology/Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574888/
https://www.ncbi.nlm.nih.gov/pubmed/33077473
http://dx.doi.org/10.1136/bmjdrc-2020-001278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574888/
https://www.ncbi.nlm.nih.gov/pubmed/33077473
http://dx.doi.org/10.1136/bmjdrc-2020-001278

Ejemplares similares